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Summary 
 Sixty-nine opiate addicts on methadone maintenance programmes at the Drug Treatment 
Centre were interviewed, all meet DSM. 3 criteria for opioid dependency. Most were young, poorly 
educated, unemployed and had involvement with both police and prison. Drug abuse started at a 
young age, all had injected drugs, heroin being the most widely abused opiate. Forty-eight (70%) 
were HIV (Human Immunodeficiency Virus) positive. Since diagnosis these individuals had made 
significant changes in their injecting practices and sexual behaviour. However, despite this positive 
change, there remained a high level of at risk behaviour for further HIV transmission. 
Introduction 
 The opiate epidemic in Dublin1, first reported in the early and mid eighties, remains a 
major problem and this has been reflected in the large number of attenders at the Drug Treatment 
Centre. In 1982-83, a study carried out by the Medico Social Research Board2 found that in the 
north inner city area the prevalence of heroin abuse was 10% in the 15-24 years age group. 
 The high risk of HIV (Human Immunodeficiency Virus) infection among injecting drug 
users who share equipment is well known as is their potential to act as a bridging group for further 
spread of the virus to the general community3. It highlights the importance of continued efforts to 
control the spread of drug abuse, the need for wide ranging treatment facilities for those addicts 
seeking treatment and the necessity to encourage those addicts who continue to use drugs to act 
more responsibly and alter their at-risk behaviour. A recent report by Robertson et al.4, suggests 
that injecting addicts, especially those who are HIV seropositive, are indeed receptive to advice 
concerning at-risk behaviour and capable of subsequent behavioural change. 
 
 The HIV seropositive prevalence rates among different groups of intravenous drug abusers 
shows much geographical variation. High rates (seroprevalence of 50% of greater are found in 
regions of Southern Italy and Spain, while much lower rates (seroprevalence of less than 20% are 
reported from Denmark and Sweden5. In the United Kingdom particularly high rates are found 
among drug users in Edinburgh compared with Glasgow and London6. By the end of 1988, 1788 
individuals in Scotland were HIV positive and of these 55% were drug users mainly concentrated in 
Edinburgh7. By comparison in the Republic of Ireland by December 1988, 794 people were HIV 
positive, of these 436 (54.9%) were intravenous drug users and 53 were children born to drug 
abusers. In total 3107 intravenous drug users were tested giving a seroprevalence rate for IV drug 
users of 14% (436/3107) (Prof. I. Hillary, Department of Medical Microbiology, University College 
Dublin, personal communication). It is likely, however, that true seroprevalence is higher given that 
many IV drug users have not been tested and that a percentage of those previously found to be HIV 
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negative many subsequently seroconvert, especially if they continue to share equipment. Multiple 
testing by individuals may also affect seroprevalance rates. 
 In the present study we sought to investigate the extent of at-risk behaviour for HIV 
transmission among those known to be sero-positive and measure the degree (if any) of positive 
change in such behaviour. 
Method 
 All those patients attending the Drug Treatment Centre at the start of November 1988 who 
were receiving methadone maintenance programmes were selected for possible inclusion in the 
study (N=70). Patients receiving this programme are in general those addicts who, despite repeated 
detoxification, fail to remain abstinent and/or those addicts who experience the additional difficulty 
of coping with the knowledge of being seropositive for HIV. Pregnant opiate addicts are maintained 
on a relatively low dose methadone regime during pregnancy. The goal of eventually becoming 
drug free is promoted in all patients. 
 Patients attend the clinic on a daily basis for methadone (Physeptone-Linctus – average  
dosage 30mg daily) and for supervised urinalysis. Such patients participated in regular group 
therapy, occupational therapy and receive individual counselling. Family members attend support 
groups and special facilities are available for addicted mothers including a crèche for their children. 
 Of the 70 patients selected for inclusion and asked to participate in the study, none refused. 
One patient was subsequently excluded as he stopped attending the clinic. The study sample 
therefore comprised of 69 patients (38 males and 31 females), all meet DSM 3 criteria8 for opioid 
dependency. A questionnaire was formulated to gather standardised information on social and 
demographic characteristics, relevant clinical details and drug history. 
 The questionnaire also included questions on sexual and needle sharing practices in order 
to elucidate the level of at-risk behaviour for HIV transmission. The questionnaires were completed 
by one of the authors (HW) during individual interviews with the patients. Where necessary, the 
information was validated and additional information gathered by reference to the patients’ clinical 
records. The study was carried out in November and December 1988. The data was tabulated using 
a computer programme. In the case of one patient, it was found to be incomplete. The completed 
parts of this questionnaire were included in the overall statistical analysis. 
Subjects 
 The characteristics of the sample were as follows: 
 The mean age was 27.8 years (S.D. 4.9). Age distribution ranged from 18-39 years. 
 38 were males (55%). 31 were females (45%). (N=69). 
 22 were single (32%). 11 married (16%), 7 married but separated (10%) and 29 were 
cohabitating with a partner 42%). 
 33 (48%) of the sample reported having a partner who also abused drugs. The majority, 59 
(85%) lived in local authority housing with the remaining living in private or rented 
accommodation. 
 The mean number of children for the group as a whole was 2 (S.D. 1.4). 14 had no children 
(18%). 
 24 had a father with alcoholism (35%), while 7 reported psychiatric illness in the father 
(10%). 9 had mothers with an alcohol problem (13%) and 13 had a mother with psychiatric illness 
(19%). 
 With regard to siblings, most patients came from large families, the mean number of 
siblings being six. 34 had at least one sibling (49%) with a history of drug abuse. 
 The mean age on leaving school was 13.9 years (S.D. 1.6). 49 had no formal educational 
qualifications (71%). 
 61 were unemployed (88%) during the two years prior to the interview. 
 51 (74%) had served prison sentences and of these 37 (73%) admitted to injecting drugs 
while in prison on at least one occasion. A history of jaundice or hepatitis was reported by 41 (59%) 
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of the sample, 46 (67%) reported skin infections, or abscesses, while 33 (48%) reported non 
intentional overdose. 
 The mean age of first drug use (excluding alcohol and tobacco) was 15.8 years (S.D. 3.6). 
62 of the sample had used some drugs by 18 years of age (90%). 
 Cannabis was the first drug used by 33 of the sample (48%). Opiates were used by 22 
(32%), LSD by 4 (6%). Cocaine, Benzodiazepines and cough preparations by 3 (4%) respectively, 
and Barbiturates by 1 (1%). 
 Mean age of onset of first dependency defined as continuous daily use for one month or 
more was 18.8 years (S.D. 3.6), range 12-33 years. 
 The mean age of first presentation for treatment was 20.5 years. Prior to being commenced 
on the maintenance programme, all had used more than one drug, mainly opiates. Heroin was used 
by 67 (97%) of the sample, 62 (90%) reporting it as the drug they used most frequently. 
Results 
 Current HIV status : Forty-eight (70%) were sero-positive, 16 (23%) were sero-negative 
and HIV status was unknown in 5 (7%). The mean duration of time since diagnosis was 28.5 
months, range 2-39 months (S.D. 10.2). Eighteen individuals (26%) reported that their partner was 
sero-positive, 23 (32%) had partners who were sero-negative and 22% had partners whose status 
was unknown (20%) had no regular partner). 
 Those who are sero-positive (N=48) were asked about their needle sharing and sexual 
activities since becoming sero-positive. They were asked about the same behaviour prior to sero-
conversion. 
 Sexual behaviour: Since becoming sero-positive, 42 individuals (88%) remained sexually 
active, the majority, 27 (64%) with one partner. Seven (17%) admitted that they did not always 
inform the sexual partner(s) of their HIV status. Of those who were sero-positive and sexually 
active (42/48), 15 (36%) denied using condoms, 11 (26%) said they use them sometimes and 16 
(38%) claimed they used condoms always. Prior to sero-conversion, all but one patient (98%, 
47/48) were sexually active. Forty-one (87%) claimed that they never used condoms, 5 (11%) used 
condoms sometimes, with only one (2%) always. There were 15 female patients who were sero-
positive and of these, eight had become pregnant since sero-conversion. 
 Equipment sharing activity: Despite being sero-positive, 30 patients (63%) admitted to 
having continued to share injecting equipment. Of these, 6 (20%) said they did so regularly (more 
than once per month), with 24 (80%) only sharing occasionally (less than once per month). Eleven 
(37%) said they limited sharing to one other person while 19 (63%) had shared with more than one 
other person. Prior to becoming sero-positive, almost all (47/48, 98%) had shared needles, 41 
(87%) did so frequently (more than once per month) and 42 (89%) admitted to having shared with 
more than one other person. 
 Evidence of change was calculated by comparing behaviour prior to and subsequent to the 
patient being diagnosed sero-positive. The changes in the percentages found before and after 
diagnosis were analysed using the McNemar test for matched pairs data9. Results are summarized 
in Table I. 
Discussion 
 A number of recent papers4,10,11,12 have reported on risk behaviour for HIV infection 
among different groups of injecting users and commented on changes in such behaviour as a result 
of AIDS awareness. Hart et al10 reported that 62% of their sample of London addicts had made 
changes in their drug use (reduced sharing, reduced injecting, etc.) However, 69% had made no 
changes in their sexual behaviour. Stimson et al11 reporting on attenders to needle exchange 
programmes in the U.K., found that the majority had made changes in injecting practices but again 
changes in sexual behaviour  
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TABLE I 
Behavioural change following diagnosis of HIV infection. 
N=48 
Number of Patients Before After X2 Test 
Sharing needles 
Sharing frequently 
Sharing with 2 or more others 
Using condoms 
 98% 
 87% 
 89% 
 13% 
 63% 
 20% 
 63% 
 64% 
 (P<0.001) 
 (P<0.001) 
 (P<0.01) 
 (P<0.001 
 
were less common. In another sample of London addicts, Power et al12 found that 54% had 
substantially reduced their risk behaviour. Interestingly, of the six people who were HIV positive in 
that study, all had altered behaviour since having been tested. The study did not, however, address 
the sexual practices of the clients. In Edinburgh, Robertson et al4 reported significant changes in all 
aspects of drug use and sexual behaviour in 49 intravenous heroin addicts. Changes were most 
marked in those infected with HIV. Like the present study, their clients had a high rate of 
seropositivity (59%). 
 In the present study, we look specifically at those patients known to be sero-positive 
(N=48) and investigated whether they had altered their behaviour as a result of being infected. 
Results were encouraging. The number of addicts sharing injecting equipment reduced from 47 
(98%) to 30 (63%). Of those who continued to share after diagnosis, only 6 (20%) did so regularly. 
Forty-one (87%) had shared regularly prior to diagnosis. We also found a significant reduction in 
the number of addicts sharing with two or more others, 42 (89%) to 19 (63%). Prior to diagnosis 47 
(98%) had been sexually active and only 6 (13%) ever used condoms. Forty-two patients (88%) 
remained sexually active after diagnosis but the number using condoms had increased significantly 
to 27 (64%). Our findings support the results of previous work4,10,11,12 and suggest that our sero-
positive addicts, like other groups of addicts, are capable of altering at risk behaviour for further 
HIV infection. 
 However, a number of disturbing facts also emerged from the study and merit attention. 
Despite being sero-positive 30 individuals (63%) had continued to share injecting equipment (even 
if at a reduced risk level) and more than one-third who remained sexually active, did not use 
condoms. The fact that these individuals continue to facilitate further transmission of the virus is 
worrying. It was beyond the scope of the present study to enquire into the reasons why these 
individuals were unable/unwilling to alter at risk behaviour. Some did claim that they restricted 
such behaviour to others known to be sero-positive also. Another cause for concern was that since 
sero-conversion, eight out of fifteen sero-positive females (53%) had become pregnant. Indeed, in a 
previous report13 from our centre it was found that 43% of pregnant sero-positive addicts 
subsequently became pregnant again. This was despite the fact that pregnant sero-positive addicts 
attend a special programme and receive repeated counselling with regard to the risks of pregnancy, 
to both mother and child. Over a quarter (26%) of the sample had a partner who was also sero-
positive. It is uncertain whether these partners had become infected through their own injecting 
practices (48% of the addicts had partners who also abused drugs) or whether infection was a result 
of sexual transmission. 
 Of all those interviewed (N=69), 51 (74%) had served prison sentences and of those, 37 
(73%) admitted to having injected drugs while in custody. Given the high level of HIV infection in 
the group and the likelihood of illicit sharing while in prison, the present findings support the 
concern expressed by others regarding the potential for the spread of HIV infection in prisons.14  
 The validity of self-reported information from addicts is often questioned. Benson et al15 
however, found that drug addicts gave an unexpectedly high degree of truthful information. In the 
present study, information received during interview corresponded closely with data accumulated in 
the patients’ clinical records. 
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 We do not claim that the group studied is representative of all opiate abusers in Dublin. 
The sample was drawn from 
TABLE II 
Comparison with other studies of opiate abuse in Dublin. 
Author: Dean, Bradshaw 
Lavelle 
(1983) 
O’Kelly 
et al 
(1986) 
O’Connor 
et al 
(1986) 
O’Connor 
et al 
(1988) 
Williams 
et al 
(1990) 
Setting: Inner City 
Area 
Inner City 
General 
Practice 
City A & E 
Departments 
 
Pregnant 
Addicts. 
Drug Treat- 
ment Centre 
Maintenance 
Programme. 
Drug Treat- 
ment Centre 
Sample Size: 
Age: 
88 
15 - 24y 
67 
– 
73 
26y (mean) 
(14-50y) 
45 
23.3y (mean) 
(16-34y) 
69 
27.8y (mean) 
(18-39y) 
Local Authority 
Housing: 
 
– 
 
88% 
 
– 
 
95% 
 
85% 
Family history 
of Alcoholism: 
 
34% 
 
40% 
 
– 
 
50% 
 
35% 
Poor Educational 
Attainment: 
67% 
(left school 
before 15y 
of age 
95% 
(no formal 
examinations) 
95% 
 
 
 
– 
– 
 
 
 
– 
70% 
 
 
 
89% 
65% 
 
 
 
71% 
Unemployed: 95% 98% 63% 100% 87% 
Criminal History 
Served Prison 
Sentence: 
 
64% 
 
40% 
 
– 
 
95% 
 
74% 
Injected Drugs: 92% 100% 59% 100% 100% 
Early Onset 
of Abuse: 
 
75% 
(used Heroin 
by 19y) 
 
57% 
(used Heroin 
by 19y) 
 
– 
– 
 
First used 
drugs 16.5y 
(mean) 
47% first 
used Heroin 
 
60% 
(Opiate 
dependent 
by 18y) 
Those addicts attending our clinic and receiving methadone maintenance programmes. 
This represents a group of addicts who in general have failed previous attempts at detoxification 
and who have a long history of attendance (albeit punctuated by episodes of relapse and periods in 
prison). Despite these and other limitations (definitions, methods used etc.) many of their general 
characteristics are comparable with other reports on opiate abuse in Dublin16,17,18, (Table II). The 
present study limited its investigation of behavioural change to those known to be HIV sero-
positive. We are unable to say at present whether similar patterns of change can be applied to those 
individuals who were sero-negative (or whose status was unknown). It is an area that would merit 
further research. 
 In summary, our attenders represent a young, unemployed socially deprived group. They 
come from disturbed backgrounds and are poorly educated. There is a long history of illicit drug 
abuse. All injected opiates intravenously, mainly heroin. Since diagnosis those who are HIV sero-
positive (N=48) had made significant alterations in their at risk behaviour for HIV transmission. We 
however, see no case for complacency. There remains a large number of sero-positive individuals 
who continue to act irresponsibly and in doing so, put others at risk of infection. It appears that at 
risk behaviour has been reduced but not eliminated. 
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